Product LaunchProduct News

RWEOne Launches AI Validation Engine v4 with Predictive SDV

June 2, 2026 3 min readRWEOne Press Office

Predictive SDV prioritization allows CRA teams to focus their 100% SDV effort on the 15% of visits and data points that actually carry risk.

FOR IMMEDIATE RELEASE

Boston — June 2, 2026 — RWEOne today announced the general availability of Version 4 of its industry-leading AI-driven Validation Engine. Building on the v3 baseline that cut Phase 4 post-market timelines by 45% for a top-20 pharma sponsor, v4 introduces predictive Source Data Verification (SDV) prioritization.

What's New in Validation Engine v4

  • Predictive SDV prioritization model: ranks every patient visit by composite risk score, directing CRA SDV effort to the 15% highest-risk visits
  • Additional 35% reduction in manual SDV workload on top of v3 baseline savings in early adopter deployments
  • New multivariate anomaly detection layer tuned to lab-to-imaging cross-signal correlations
  • Explainability dashboard: every AI-generated validation decision includes feature weights and confidence score for CRA and inspector review

Early Adopter Results

Predictive SDV changed how we staff our monitoring team. We are covering more patients with fewer CRA hours, and we are catching more real risks because our team is no longer just checking boxes on 100% SDV plans.

— Head of Clinical Monitoring, Top-15 Global Pharma (Early Adopter)

All existing RWEOne enterprise sponsors will receive the v4 upgrade as part of their platform license at no additional charge during their next scheduled maintenance window.

Media Contact:
RWEOne Press Office
[email protected]